Carnitor® Injection Corrects DCD, Which Can Improve Hematocrit (Hct)1,2
"We concluded that abnormalities in the deformability of RBCs improved after L-carnitine and that this was responsible for the increase in the hematocrit." 2
NKF Practice Recommendations:
"In dialysis patients, there is an inverse correlation between plasma concentrations and dose requirements for rHuEPO. The beneficial effect of L-carnitine appears to be related to stabilization of the red blood cell (RBC) membrane, thereby improving RBC survival time." 1
"Randomized clinical studies with L-carnitine therapy have shown significant increases in hematocrit with or without rHuEPO therapy…" 1
References: 1. Eknoyan G, et al: Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder: National Kidney Foundation: Carnitine Consensus Conference. Am J Kidney Dis 2003;41:868-876. 2. Nikolaos S, et al: Effect of L-carnitine supplementation on red blood cells deformability in hemodialysis patients. Ren Fail 2000;22:73-80.